Ali H. Mokdad
Ali H. Mokdad is chief strategy officer for Population Health at the University of Washington and professor of Health Metrics Sciences at the Institute for Health Metrics and Evaluation. Prior to working at the University of Washington, Mokdad worked at the U.S. Centers for Disease Control and Prevention. He has published groundbreaking research on local-level disease trends and leading risk factors for poor health. His work on obesity is among the most highly cited in the field.
The 10 Americas: How Geography, Race, and Income Shape U.S. Life Expectancy
The differences in U.S. life expectancy are so large it's as if the population lives in separate Americas instead of one
The Last Mile of Nutrition
Introducing a new way to measure the health impacts of community-based food programs and farmers markets
For Syrian Refugees, Deadly Hazards Lurk in Camps
Substandard living conditions leave Syrian refugees at a higher risk of injury than native Lebanese people
The Quest for Social Connection and Well-Being
Scientists have been slow at developing strategies that measure and promote well-being within communities
Defanging COVID-19 in China
China has successfully managed the pandemic, omicron could change that
Let Ukraine Set the Example for How to Treat Children Caught in Conflict
The world should protect the safety of children in all war zones, including those who don't make the news
The Centers for Disease Control and Prevention Needs to Be Reformed
A new CDC era calls for empowering local health experts and explaining "the why" behind policy recommendations
What Happens When Zero-COVID Countries Lift Restrictions
How Singapore, Australia, Vietnam, and others are transitioning
Injuries: A Leading Killer of Youth in Lebanon
Traffic accidents are wreaking havoc on young lives, especially children who are refugees
A Sensible Approach to Omicron
New estimates suggest omicron is just 3 percent as deadly as delta
Time for a Smart Approach to Boosters
Some privileged Americans are seeking out supplementary COVID-19 vaccines, but the most vulnerable should be prioritized